HR 6832 · 117th Congress
To amend the Federal Food, Drug, and Cosmetic Act and the Defense Production Act of 1950 to prohibit the Federal Government from limiting State access to key therapies, such as monoclonal antibodies, and from prioritizing Federal contracts over State contracts relating to purchasing supplies to combat the COVID-19 pandemic.
This bill hasn't been enriched yet — fetch cosponsors, actions, subjects, titles, and summaries from Congress.gov.
Latest action
2022-02-28 — Referred to the Subcommittee on Health.
Sponsor
Michael CloudCosponsors
Cosponsors not yet fetched. Run
concord scrape bills enrich --bill-ids 117-hr-6832
to populate.
Action history
Action history not yet fetched. Run
concord scrape bills enrich --bill-ids 117-hr-6832
to populate.
Subjects
Subjects not yet fetched. Run
concord scrape bills enrich --bill-ids 117-hr-6832
to populate.
Titles
Titles not yet fetched. Run
concord scrape bills enrich --bill-ids 117-hr-6832
to populate.
Summaries
Summaries not yet fetched. Run
concord scrape bills enrich --bill-ids 117-hr-6832
to populate.
Vote history
No votes recorded for this bill yet.
Coming in later phases
Committee path (Phase 4)
Committee referrals and reports will appear here.
Search within this bill (Phase 5)
Bill text will become searchable here.